CopyMark Law Group
4.9/5
Drawing for NANOFORM

USPTO serial 78311533

NANOFORM

Reviewed by CopyMark Law Group

Reg. 3039993Status 710
Filing date
Status date
Registration date
Jan 10, 2006
Examiner
SNAPP, TINA LOUISE
Law office
TMO LAW OFFICE 116

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with NANOFORM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cynthia J. Lee

Cynthia J. Lee THOMAS, KAYDEN, HORSTEMEYER & RISLEY400 Interstate North Parkway, SESuite 1500ATLANTA, GA 30339

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disordersSECTION 8 - CANCELLED—
042Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and veterinary preparations and substances; medical and scientific research, namely, conducting clinical trials involving pharmaceutical and veterinary preparations and substancesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2016CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Feb 18, 2012NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Feb 18, 2012C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Feb 18, 2012APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 11, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jan 9, 2012E815TEAS SECTION 8 & 15 RECEIVED—
Jan 10, 2006R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 18, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2005NPUBNOTICE OF PUBLICATION—
Jun 29, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jun 24, 2005ALIEASSIGNED TO LIE—
Jun 22, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 21, 2005ACECAMENDMENT FROM APPLICANT ENTERED—
Jun 14, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 14, 2005TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 12, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2004MAILPAPER RECEIVED—
May 12, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 28, 2004DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance